company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1016123.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3387733.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4403856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4383856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4383856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4383856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4383856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4383856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5100000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5100000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5100885.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2038909.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2129573.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4168482.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4168482.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,98.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,98.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4168384.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4168384.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4168384.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4168384.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5300000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5300000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.79
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5246089.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 15:59:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2106877.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4652056.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6758933.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6758933.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2009.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2009.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6756924.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6756924.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6756924.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6756924.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5500000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.22
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5500000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.22
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5531263.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:11:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.22
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,613932.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,613932.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,613932.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2701347.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6931643.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9632990.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9019058.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-5520.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2107.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3413.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9015645.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9015645.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9015645.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,707342.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9722987.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5400000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.77
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5400000.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.77
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5397599.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.77
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2274467.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2274467.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2274467.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3684880.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8334108.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12018988.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9744521.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11014.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11014.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9733507.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9733507.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9733507.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,634794.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10368301.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17925296.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1288629.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1288629.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1288629.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6333123.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9343972.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15677095.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14388466.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51624.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,51624.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14336842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14336842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14336842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14336842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24080420.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:07:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1302789.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1302789.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1302789.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6461675.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11796455.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18258130.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16955341.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,54781.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,54781.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16900560.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16900560.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16900560.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16900560.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24100000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24100000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24138020.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:30:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17197789.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17197789.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17197789.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6872493.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16554779.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23427272.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6229483.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-192033.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-117419.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,74614.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6154869.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6154869.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6154869.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6154869.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22700000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22700000.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22710105.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1288628.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1288628.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1288628.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8873861.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18251900.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27125761.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25837133.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,260422.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,260422.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25576711.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25576711.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25576711.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25576711.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.95
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.95
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26807380.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.95
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1288629.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1288629.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1288629.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10676752.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19621536.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30298288.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29009659.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-333544.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,333544.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28676115.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28676115.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28676115.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28676115.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27600000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.04
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27600000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.04
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27456954.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:55:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.04
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1302789.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1302789.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1302789.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12049954.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22384109.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34434063.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33131274.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-568867.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,568867.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32562407.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32562407.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32562407.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32562407.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30400000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.07
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30400000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.07
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30368354.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:05:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.07
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16302954.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16302954.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16302954.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16469433.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37254455.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53723888.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37420934.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-843589.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-260422.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,583167.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36837767.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36837767.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36837767.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36837767.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28800000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.23
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28800000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.23
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28804133.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.23
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1274000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1274000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1274000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21413000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32735000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54148000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-52874000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,585000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,585000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52289000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52289000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52289000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-52289000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30800000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.7
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30800000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.7
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30771867.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.7
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1483000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1483000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1483000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26729000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36059000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,15696000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78484000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-77001000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-532000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,532000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-76469000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2109000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74360000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74360000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-74360000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30968450.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.4
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30968450.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.4
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:20:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.4
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1900000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26641000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41091000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67732000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-65832000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-1112000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1112000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64720000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,292000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65012000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65012000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65012000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34200000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.9
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34200000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.9
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34258328.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:37:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.9
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7409000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7409000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7409000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36341000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33879000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70220000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-62811000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2429000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-585000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1844000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60967000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,854000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61821000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61821000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61821000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33200000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.63
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33200000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.63
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33242072.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.63
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15676000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15676000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,990000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,990000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14686000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33489000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30109000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63598000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48912000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2185000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,364000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2549000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46363000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46373000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46373000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46373000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37100000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.25
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37100000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.25
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37046235.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.25
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25185000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25185000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4511000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4511000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20674000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29749000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25524000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55273000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34599000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2521000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2255000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,110000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,114776000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,80177000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80165000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,80165000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,80165000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37254003.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38702598.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.07
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37300000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:14:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10707000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10707000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,318000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,318000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10389000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29305000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32829000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62134000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51745000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2714000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1672000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4386000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47359000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47357000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47357000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47357000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37600000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.26
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37600000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.26
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37498616.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:35:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.26
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13157000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13157000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2096000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2096000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11061000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32352000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37092000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69444000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58383000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2574000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-9369000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6795000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-65178000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,79000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65257000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65257000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65257000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37400000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.75
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37400000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.67
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37366782.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.75
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20771000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20771000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3495000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3495000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17276000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38291000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35831000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74122000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56846000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2702000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-211000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2491000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54355000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54358000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54358000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54358000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.43
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.43
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37906944.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.43
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13503000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13503000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1297000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1297000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12206000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36407000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42244000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78651000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66445000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2670000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-422000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2248000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64197000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64230000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64230000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64230000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38686924.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.66
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38686924.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.66
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38700000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:14:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.66
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22447000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22447000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5043000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5043000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17404000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41407000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44655000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,86062000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68658000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2095000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-13000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2082000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-66576000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66602000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66602000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-66602000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38700000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.72
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38700000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.72
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38747658.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:35:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.72
